Vestmark Advisory Solutions’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,084
Closed -$178K 790
2023
Q2
$178K Sell
15,084
-966
-6% -$11K 0.01% 853
2023
Q1
$185K Buy
16,050
+251
+2% +$3.1K 0.01% 832
2022
Q4
$196K Buy
15,799
+412
+3% +$5.25K 0.01% 810
2022
Q3
$202K Buy
15,387
+1,057
+7% +$15.6K 0.01% 783
2022
Q2
$200K Sell
14,330
-4,372
-23% -$58.5K 0.01% 814
2022
Q1
$278K Sell
18,702
-805
-4% -$11K 0.02% 737
2021
Q4
$264K Sell
19,507
-16,647
-46% -$236K 0.01% 750
2021
Q3
$532K Buy
36,154
+6,072
+20% +$103K 0.04% 475
2021
Q2
$547K Buy
30,082
+15,573
+107% +$277K 0.04% 450
2021
Q1
$252K Buy
14,509
+81
+0.6% +$1.42K 0.02% 648
2020
Q4
$251K Buy
14,428
+891
+7% +$14.2K 0.03% 522
2020
Q3
$187K Buy
13,537
+263
+2% +$3.86K 0.03% 536
2020
Q2
$192K Buy
13,274
+2,162
+19% +$28.4K 0.03% 523
2020
Q1
$122K Buy
+11,112
New +$205K 0.02% 465

Other funds holding SBRA

Vestmark Advisory Solutions's SBRA Position: Q3 2023 in Review

Vestmark Advisory Solutions sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 15,084 shares — an estimated $178K sold.

Vestmark Advisory Solutions first reported a position in SBRA in Q1 2020 and held it in 14 quarters. The position peaked at $547K in Q2 2021. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • Vestmark Advisory Solutions reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 15,084 Sabra Healthcare REIT shares in Q3 2023, an estimated $178K.
  • Vestmark Advisory Solutions first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 14 quarters.
  • Vestmark Advisory Solutions's Sabra Healthcare REIT position peaked at $547K in Q2 2021.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2023, filed 6 Nov 2023.